News from AACR 2024: Sunday’s highlights
Drug Discovery World
APRIL 8, 2024
In December 2023, Pfizer announced that it had chosen to donate the rights of its royalties from the sale of Bavencio (avelumab) in the United States to the AACR, as an acknowledgment of the AACR’s dedication to sustained innovation in cancer research and treatment.
Let's personalize your content